ACHV
Achieve Life Sciences, Inc.
Biotechnology · Healthcare · United States
6.83
close · 2026-10-30
value
67
cheaper than peers67
quality
6
stronger fundamentals6
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 2 years ago | -3.5% | 79 |
| cash flow yield, 1 year ago | -4.2% | 78 |
| cash flow yield, latest year | -7.0% | 71 |
| cash flow yield, 3 years ago | -5.3% | 67 |
| earnings yield, 2 years ago | -22.0% | 61 |
| earnings yield, 1 year ago | -18.2% | 60 |
| earnings yield, latest year | -18.3% | 58 |
| earnings yield, 3 years ago | -58.6% | 49 |
| price to book | 35.67× | 5 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| debt to equity | 140.0% | 7 |
| return on equity | -496.1% | 5 |
3 of 4 measures available
Facts
| market cap | $704M |
| free cash flow | -$26.9M |
| employees | 28 |
| first trade | 1995-10-12 |
| next earnings | 2026-08-11 |
| fundamentals updated | 2026-08-11 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.25 | -1.24 | -1.50 | -4.00 |
| free cash flow | -$49.5M | -$29.8M | -$24.5M | -$37.6M |
| net income | -$54.6M | -$39.8M | -$29.8M | -$42.4M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | -$408,000 | -$904,000 | -$528,000 | $0 |